Claus Kremoser PhD, MSc
Biotechnology, Pharmacy and Medicine
Ludwigshafen am rhein, Rheinland-Pfalz, Germany
Connect with the speaker?
Dr. Kremoser has studied biochemistry in Tübingen and Munich and has received his PhD based on work in the lab of Friedrich Bonhoeffer at the Max-Planck-Institute in Tübingen. In 1996, he became the first member of EY´s newly established life science practice in Germany to coordinate the first German EY biotech report which is now in its 18th year. After a position as VP Corporate Development at LION bioscience where he was instrumental in LION´s 100 M bioinformatics collaboration with Bayer AG and LION´s 220 M IPO in 2000, he became cofounder and CEO of Phenex in 2002, a position he has maintained since then.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
2nd Annual NASH Summit Europe 2018
In-Person Event
Gastroenterology
Oct 22 - 24, 2018
Frankfurt, Hessen, DE
European Pharma Market Research Conference (EPMRC) 2017
- In-Person Event
- Research and Clinical Research
- Oct 24 - 25, 2017
- Dusseldorf, Nordrhein-Westfalen, DE
Nonalcoholic Steatohepatitis (NASH) Summit Europe 2017
- In-Person Event
- Gastroenterology
- Oct 10 - 12, 2017
- Frankfurt am Main, Hessen, DE
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com